
Novel RNA sequencing-based liquid biopsy platform demonstrates potential for early detection and monitoring of colorectal cancer
Exai Bio, a next-generation liquid biopsy company, and researchers at UCSF are presenting data from…
Exai Bio, a next-generation liquid biopsy company, and researchers at UCSF are presenting data from…
CD Genomics has recently launched the Nanopore direct RNA sequencing service for identifying new genes,…
High-throughput sequencing methods mainly based on Illumina platforms have benefited the entire field of biology…
Expression levels of pathological dysregulated neurodegenerative genes of both Alzheimer’s and Parkinson’s disease were significantly…
Veracyte today announced that new clinical validation data published online in Thyroid show that the company’s RNA…
IgGenix, a biotechnology company taking a revolutionary approach to directly alleviate allergic disease, today announced…
Aspen Neuroscience, Inc. Director of Bioinformatics, Roy Williams, Ph.D., presented NeuriTest for the first time publicly last…
Fluent BioSciences, a biotechnology company focused on making single-cell analysis simple and accessible to every…
Bio-Rad Laboratories, a global leader in life science research and clinical diagnostic products, today announced…
Parse Biosciences, a leading provider of scalable single-cell sequencing solutions, today announced a partnership with Molecular…